复星医药:2026年第一次A股类别股东会审议不通过分拆所属子公司复星安特金至香港联交所主板上市仅向H

公司公告
Feb 27

复星医药 公告,2026年第一次临时股东会、A股类别股东会及H股类别股东会于2026年2月27日召开。临时股东会审议通过关于分拆所属子公司复星安特金至香港联交所主板上市相关议案,包括符合法律法规规定、上市方案、预案等11项议案;2026年第一次A股类别股东会未通过关于仅向H股股东提供保证配额的议案,该议案未获出席中小股东三分之二以上表决权通过;2026年第一次H股类别股东会通过了相同议案。出席会议...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10